BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21281433)

  • 1. Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study.
    Couto BG; Goldenberg RC; da Fonseca LM; Thomas J; Gutfilen B; Resende CM; Azevedo F; Mercante DR; Torres AL; Coelho HS; Maiolino A; Alves AL; Dias JV; Moreira MC; Sampaio AL; Sousa MA; Kasai-Brunswick TH; Souza SA; Campos-de-Carvalho AC; Rezende GF
    Liver Int; 2011 Mar; 31(3):391-400. PubMed ID: 21281433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow cells obtained from cirrhotic rats do not improve function or reduce fibrosis in a chronic liver disease model.
    Mannheimer EG; Quintanilha LF; Carvalho AB; Paredes BD; Gonçalves de Carvalho F; Takyia CM; Resende CM; Ferreira da Motta Rezende G; Campos de Carvalho AC; Schanaider A; dos Santos Goldenberg RC
    Clin Transplant; 2011; 25(1):54-60. PubMed ID: 20047614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of autologous CD34-depleted bone marrow mononuclear cell transplantation via the hepatic artery in five patients with liver failure.
    Park CH; Bae SH; Kim HY; Kim JK; Jung ES; Chun HJ; Song MJ; Lee SE; Cho SG; Lee JW; Choi JY; Yoon SK; Han NI; Lee YS
    Cytotherapy; 2013 Dec; 15(12):1571-9. PubMed ID: 23849977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease.
    Cucchetti A; Ercolani G; Cescon M; Ravaioli M; Zanello M; Del Gaudio M; Lauro A; Vivarelli M; Grazi GL; Pinna AD
    J Am Coll Surg; 2006 Nov; 203(5):670-6. PubMed ID: 17084328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocarcinoma in a child with cholesterol ester storage disease.
    Riva S; Spada M; Sciveres M; Minervini M; Cintorino D; Maggiore G; Gridelli B
    Dig Liver Dis; 2008 Sep; 40(9):784. PubMed ID: 18339594
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neoplastic degeneration of liver cirrhosis: comments on personal cases].
    Giuliani-Piccari G; Dal Monte PR
    G Clin Med; 1982 Oct; 63(10):731-6. PubMed ID: 6303881
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracoronary administration of autologous bone marrow mononuclear cells in patients with chronic ischemic symptomatic cardiomyopathy: 5 years follow-up.
    Blatt A; Minha S; Moravsky G; Vered Z; Krakover R
    Isr Med Assoc J; 2010 Dec; 12(12):738-41. PubMed ID: 21348401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
    Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
    J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic staging and radiofrequency of hepatocellular carcinoma in liver ci rrhosis. A "bridge" treatment to liver transplantation.
    Casaccia M; Andorno E; Nardi I; Santori G; Troilo B; Barabino G; Di Domenico S; Panaro F; Valente U
    Hepatogastroenterology; 2009; 56(91-92):793-7. PubMed ID: 19621704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications and results of liver transplantation in the treatment of hepatocellular carcinoma in cirrhosis].
    Adam R; Castaing D; Azoulay D; Majno P; Samuel D; Bismuth H
    Ann Chir; 1998; 52(6):547-57. PubMed ID: 9752505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatic cirrhosis with and without implanted carcinoma. Apropos of 100 cases with necropsy].
    Pérez Flores R; Cortés Cansino J; Oliva Aldamiz H; Hernández Guío C
    Rev Clin Esp; 1987 Nov; 181(7):356-60. PubMed ID: 2827249
    [No Abstract]   [Full Text] [Related]  

  • 12. [Does liver transplantation have the greatest chance of healing in cirrhosis with hepatocellular carcinoma?].
    Schentke KU
    Z Gastroenterol; 1998 Feb; 36(2):197-8. PubMed ID: 9544504
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship of hepatocellular carcinoma, liver cirrhosis, and hepatitis B virus. A pathologic study of 1,069 autopsy cases in different areas of China.
    Ying YY; Yan RQ; Xu BD; Wang LX; Wang YL; Qian YL
    Chin Med J (Engl); 1984 Oct; 97(10):758-64. PubMed ID: 6100440
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinicopathological aspects of primary hepatocellular carcinoma occurring in patients with liver cirrhosis.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Sep; 7(5):589-605. PubMed ID: 6190271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraportal Infusion of Bone Marrow Mononuclear or CD133+ Cells in Patients With Decompensated Cirrhosis: A Double-Blind Randomized Controlled Trial.
    Mohamadnejad M; Vosough M; Moossavi S; Nikfam S; Mardpour S; Akhlaghpoor S; Ashrafi M; Azimian V; Jarughi N; Hosseini SE; Moeininia F; Bagheri M; Sharafkhah M; Aghdami N; Malekzadeh R; Baharvand H
    Stem Cells Transl Med; 2016 Jan; 5(1):87-94. PubMed ID: 26659833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.
    Terai S; Ishikawa T; Omori K; Aoyama K; Marumoto Y; Urata Y; Yokoyama Y; Uchida K; Yamasaki T; Fujii Y; Okita K; Sakaida I
    Stem Cells; 2006 Oct; 24(10):2292-8. PubMed ID: 16778155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-cell dysplasia and hepatocellular carcinoma.
    Podda M; Roncalli M; Battezzati PM; Borzio M; Bruno S; Servida E; Coggi G
    Ital J Gastroenterol; 1992 Jan; 24(1):39-42. PubMed ID: 1315175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma.
    Habib N; Salama H; Abd El Latif Abu Median A; Isac Anis I; Abd Al Aziz RA; Sarraf C; Mitry R; Havlik R; Seth P; Hartwigsen J; Bhushan R; Nicholls J; Jensen S
    Cancer Gene Ther; 2002 Mar; 9(3):254-9. PubMed ID: 11896441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periprocedural complications by Child-Pugh class in patients undergoing transcatheter arterial embolization or chemoembolization to treat unresectable hepatocellular carcinoma at a VA medical center.
    Russell JS; Sawhney R; Monto A; Nanavati S; Davoren JB; Aslam R; Corvera CU
    Am J Surg; 2010 Nov; 200(5):659-64. PubMed ID: 21056149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
    Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
    Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.